Abstract:Although myocyte cell transplantation studies have suggested a promising therapeutic potential for myocardial infarction, a major obstacle to the development of clinical therapies for myocardial repair is the difficulties associated with obtaining relatively homogeneous ventricular myocytes for transplantation. Human embryonic stem cells (hESCs) are a promising source of cardiomyocytes. Here we report that retinoid signaling regulates the fate specification of atrial versus ventricular myocytes during cardiac differentiation of hESCs. We found that both Noggin and the pan-retinoic acid receptor antagonist BMS-189453 (RAi) significantly increased the cardiac differentiation efficiency of hESCs. To investigate retinoid functions, we compared Noggin+RAi-treated cultures with Noggin+RA-treated cultures. Our results showed that the expression levels of the ventricular-specific gene IRX-4 were radically elevated in Noggin+RAi-treated cultures. MLC-2V, another ventricular-specific marker, was expressed in the majority of the cardiomyocytes in Noggin+RAi-treated cultures, but not in the cardiomyocytes of Noggin+RA-treated cultures. Flow cytometry analysis and electrophysiological studies indicated that with 64.7 ± 0.88% (mean ±s.e.m) cardiac differentiation efficiency, 83% of the cardiomyocytes in Noggin+RAi-treated cultures had embryonic ventricular-like action potentials (APs). With 50.7 ± 1.76% cardiac differentiation efficiency, 94% of the cardiomyocytes in Noggin+RA-treated cultures had embryonic atrial-like APs. These results were further confirmed by imaging studies that assessed the patterns and properties of the Ca(2+) sparks of the cardiomyocytes from the two cultures. These findings demonstrate that retinoid signaling specifies the atrial versus ventricular differentiation of hESCs. This study also shows that relatively homogeneous embryonic atrial- and ventricular-like myocyte populations can be efficiently derived from hESCs by specifically regulating Noggin and retinoid signals.

Activin A and BMP-4 Induce Cardiomyocyte-like Cells Differentiation of Human Amniotic Epithelial Cells

Direct Differentiation of Atrial and Ventricular Myocytes from Human Embryonic Stem Cells by Alternating Retinoid Signals

Short-term BMP-4 Treatment Initiates Mesoderm Induction in Human Embryonic Stem Cells

Differentiation of human embryonic stem cells into smooth muscle cells in adherent monolayer culture.

[Differentiation of Porcine Amniotic Fluid Stem Cells into the Beating Cardiomyocytes].

In Vivo Differentiation of Human Amniotic Epithelial Cells into Cardiomyocyte-Like Cells and Cell Transplantation Effect on Myocardial Infarction in Rats: Comparison with Cord Blood and Adipose Tissue-Derived Mesenchymal Stem Cells

Efficient Cardiomyocyte Differentiation of Embryonic Stem Cells by Bone Morphogenetic Protein-2 Combined with Visceral Endoderm-Like Cells.

Cyclic adenosine 3',5'-monophosphate induces differentiation of mouse embryonic stem cells into cardiomyocytes.

Controlling the in Vitro Differentiation of Embryonic Stem Cells for Myocardial Tissue Engineering Applications.

Differentiation of Cardiomyocytes from Amniotic Fluid-Derived Mesenchymal Stem Cells by Combined Induction with Transforming Growth Factor Β1 and 5-Azacytidine

Assessment of the feasibility of human amniotic membrane stem cell-derived cardiomyocytes in vitro

Cyclic adenosine 3 0 ,5 0 -monophosphate induces differentiation of mouse embryonic stem cells into cardiomyocytes

Differentiation of Brown Adipose-Derived Stem Cells into Cardiomyocyte-Like Cells is Regulated by a Combination of Low 5-Azacytidine Concentration and Bone Morphogenetic Protein 4.

Inducing Mesenchymal Stem Cells from Adult Human Adipose Tissue to Differentiate into Cardiomyocytes in Vitro

Experimental study on differentiation of cardiomyocyte from amniotic fluid-derived mesenchymal stem cells

Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells

Differentiation of Embryonic Stem Cells towards Cardiomyocytes in Mimic Cardiac Microenvironment in vitro

The Effect of Angiotensin II, Retinoic Acid, EGCG, and Vitamin C on the Cardiomyogenic Differentiation Induction of Human Amniotic Fluid-Derived Mesenchymal Stem Cells

Rat hair-follicle-associated pluripotent (HAP) stem cells can differentiate into atrial or ventricular cardiomyocytes in culture controlled by specific supplementation

Ascorbic Acid Induces Differentiation of Human Embryonic Germ Cells Towards Cardiomyocytes

Establishment of Method to Induce Human Bone Mesenchymal Stem Cells to Differentiate into Cardiomyocytes in Vitro